Germline Variant in DPYD Enhancer Regulates Expression and Alters Sensitivity to Anti-Cancer Drug 5-Fluorouracil
A common germline variant (rs4294451) located within a novel enhancer region for the anti-cancer drug metabolism gene DPYD controls its transcription and alters cellular sensitivity to the chemotherapeutic 5-fluorouracil.